AGE-RELATED-CHANGES OF URINARY DOPAMINE EXCRETION IN HYPERTENSIVE PATIENTS

被引:0
|
作者
SCHOORS, DF
GERLO, EAM
DUPONT, AG
机构
[1] VRIJE UNIV HOSP BRUSSEL,DEPT CLIN CHEM,B-1090 BRUSSELS,BELGIUM
[2] VRIJE UNIV BRUSSELS HOSP,DEPT INTERNAL MED,B-1090 BRUSSELS,BELGIUM
来源
CARDIOLOGY IN THE ELDERLY | 1994年 / 2卷 / 03期
关键词
AGED; HYPERTENSION; DOPAMINE; METABOLIC CLEARANCE RATE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Increasing evidence suggests that the kidney is the main source of urinary dopamine and that this intrarenally formed dopamine plays a role in sodium and water homeostasis. Because older subjects are known to handle a sodium load less efficiently than younger subjects, and because the prevalence of hypertension increases with age, we found it of interest to study the effect of age on the renal production of dopamine. Methods: We retrospectively determined urinary catecholamine excretion (24-hour urine collections) of 1000 hypertensive patients and correlated the amount of catecholamines excreted with age. Results: A significant negative correlation between age and dopamine excretion (r = - 0.38, P < 0.001) and between age and creatinine excretion (r = 0.37, P < 0.001) was observed. The percentage decrease of urinary dopamine with age (0.65% per year) was comparable to the percentage decrease of urinary creatinine with age (0.55% per year). Conclusions: Urinary dopamine production decreases with age, possibly as a part of the global loss of renal function.
引用
收藏
页码:233 / 237
页数:5
相关论文
共 50 条
  • [31] AGE-RELATED-CHANGES IN SPEED OF WALKING
    HIMANN, JE
    CUNNINGHAM, DA
    RECHNITZER, PA
    PATERSON, DH
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1988, 20 (02): : 161 - 166
  • [32] AGE-RELATED-CHANGES IN DRUG DISPOSITION
    SCHMUCKER, DL
    PHARMACOLOGICAL REVIEWS, 1978, 30 (04) : 445 - 456
  • [33] Urinary proteins excretion in hypertensive patients
    Takechi, S
    Fujimoto, T
    MacHida, M
    Kanda, K
    Kakinoki, S
    Nomura, A
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 135A - 135A
  • [34] AGE-RELATED-CHANGES IN THE PHARMACOLOGY OF NIFEDIPINE
    ROBERTSON, DRC
    WALLER, DG
    RENWICK, AG
    GEORGE, CF
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 24 (02) : P244 - P245
  • [35] AGE-RELATED-CHANGES IN CONTACT HYPERSENSITIVITY
    POTOZKIN, J
    SOTER, NA
    BELSITO, DV
    CLINICAL RESEARCH, 1990, 38 (02): : A620 - A620
  • [36] AGE-RELATED-CHANGES IN THE PHARMACODYNAMICS OF VERAPAMIL
    ARNOLD, TH
    VALLNER, JJ
    TACKETT, RL
    AMERICAN HEART JOURNAL, 1985, 110 (05) : 981 - 985
  • [37] AGE-RELATED-CHANGES IN WARFARIN PHARMACODYNAMICS
    GURWITZ, JH
    AVORN, J
    ROSSDEGNAN, D
    ANSELL, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (02) : 166 - 166
  • [38] AGE-RELATED-CHANGES IN BRAIN NEUROTRANSMISSION
    PETKOV, VD
    PETKOV, VV
    STANCHEVA, SL
    GERONTOLOGY, 1988, 34 (1-2) : 14 - 21
  • [39] AGE-RELATED-CHANGES IN RAT-BRAIN MONOAMINES RELEASE - PECULIARITY OF DOPAMINE RELEASE
    CERRITO, F
    ALOISI, G
    ARMINIO, P
    JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 34 (03) : 364 - 370
  • [40] AGE-RELATED-CHANGES OF AUTONOMIC REGULATION OF THE CARDIOVASCULAR-SYSTEM IN NORMAL AND HYPERTENSIVE SUBJECTS
    SHIMADA, K
    KITAZUMI, T
    SADAKANE, N
    OZAWA, T
    OGURA, H
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1985, 7 (04) : 627 - 627